Perioperative β-blockade: Time to change the paradigm?

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 5, 2009, Pages 553-555

  Oksanen, T ^a   Hynynen, M ^a  

^a JORVI HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; METOPROLOL;

ACUTE HEART INFARCTION; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL TRIAL; DRUG CONTRAINDICATION; EDITORIAL; HEART FAILURE; HEART PROTECTION; HUMAN; HYPOTENSION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; TREATMENT INDICATION;

ADRENERGIC BETA-ANTAGONISTS; AMERICAN HOSPITAL ASSOCIATION; ANESTHESIA; CLINICAL PROTOCOLS; GUIDELINES AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; METOPROLOL; PERIOPERATIVE CARE; RISK FACTORS; UNITED STATES;

EID: 64849108825     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.01913.x     Document Type: Editorial

References (17)

1. Mangano D, Layug E, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: multicenter study of Perioperative Ischemia Research Group. N Engl J Med 1996 335 : 1713 20.
2. Poldermans D, Boersma E, Bax J, Thomson IR, van de Ven LLM, Blankensteijn JD, Baars HF, Yo T, Trocino G, Vigna C, Roelandt JRTC, van Urk H, Fioretti PM, Paelinck B. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999 341 : 1789 94.
3. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction. Lancet 1986 2 : 57 66.
4. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999 353 : 2001 7.
5. Devereaux P, Beattie W, Choi P, Badner NH, Guyatt GH, Villar JC, Cinà CS, Leslie K, Jacka JM, Montori VM, Bhandari M, Avezum A, Cavalcanti AB, Giles JW, Schicker T, Yang H, Jakobsen C-J, Yusuf S. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. Br Med J 2005 331 : 313 21.
6. Antman E, Hand M, Armstrong P, Bates E, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction). Circulation 2008 117 : 296 329.
7. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005 366 : 1622 3.
8. POISE Study Group. Effects of extendedrelease metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008 371 : 1839 47.
9. Fleisher L, Beckman J, Brown K, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007 50 : e159 241.
10. Shammash J, Trost J, Gold J, Berlin J, Golden M, Kimmel S. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001 141 : 148 53.
11. The task force on the management of stable angina pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 2006 27 : 1341 81.
12. Fleisher L, Poldermans D. Perioperative β-blockade: where do we go from here? Lancet 2008 371 : 1813 14.
13. Sear J, Giles J, Howard-Alpe G, Foex P. Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified? (editorial). Br J Anaesth 2008 101 : 135 8.
14. Kaafarani HMA, Atluri PV, Thornby J, Itani KMF. β-blockade in noncardiac surgery. Outcome at all levels of cardiac risk. Arch Surg 2008 143 : 940 4.
15. Biccard B, Sear J, Foex P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 2008 100 : 23 8.
16. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli F. Perioperative β-blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008 372 : 1962 76.
17. Boersma E, Poldermans D. β-blockers in non-cardiac surgery: haemodynamic data needed. Lancet 2008 372 : 1930 2.